By reducing time from recognition to accurate identification and treatment, you are setting them on the right clinical path. Our sepsis management program can help.
Let’s collaborate to optimize how you manage patients across the sepsis care pathway using BD solutions. The approach will include:
By focusing on the sepsis care pathway—from recognition of patients at-risk for sepsis through their treatment—using BD solutions, you can start on the journey of:
With the ultimate goal of reducing time to appropriate therapy and improving patient outcomes.
Mortality from septic shock increases 7.6% for every hour that treatment is delayed4 among patients with septic shock within the first 6 hours of onset of hypotension.
The timely identification of a patient at risk for sepsis is necessary for setting the course of action to intervene with appropriate diagnosis and treatment.
Discover our solution:
~ 80% of skin flora reside in the first five layers of our outermost skin5
Proper skin preparation kills bacteria on the skin that can potentially cause skin infection and contamination.
Discover our solution:
~ 20% of blood culture samples have been reported as underfilled in the U.S.6
Support optimal blood culture specimen collection; sufficient blood volume is a critical determinant for optimal organism recovery. The yield of pathogens recovered increases in direct proportion to the volume of blood cultured. 6
Discover our solution:
80% of sepsis deaths could be prevented by quicker diagnosis and treatment7
Decrease time to detection, followed by timely and accurate organism identification (ID) and antimicrobial susceptibility testing (AST). Reduction in transport time and faster incubation of blood cultures has been shown to reduce turnaround times and accelerate antibiotic switching.8
Discover our solutions:
BD BACTEC™ Blood Culture Media
BD BACTEC™ FX Blood Culture System
BD Kiestra™ Lab Automation System
BD Phoenix™ Automated Identification and Susceptibility Testing System
5x reduction in survival when inappropriate initial antimicrobial therapy is performed for septic shock, which occurs in ~20% of patients9
Ensuring that appropriate diagnostics are performed as early as possible to enable timely and appropriate antimicrobial therapy treatment decisions.
Discover our solutions:
BD HealthSight™ Clinical Advisor
BD Phoenix™ Automated Identification and Susceptibility Testing
BD-12850
Recognize Related Products
Now with MedMined Insights (formerly MedMined™ Surveillance Advisor)
The ChloraPrep™ preoperative skin preparation product line provides a formulation that has set the standard of care in infection prevention for over 18 years. Learn more about ChloraPrep™.
With propriety BD PentaPoint™ and BD RightGauge™ needle technology, the BD Vacutainer® UltraTouch™ push button blood collection set aims to improve the patient experience by enhancing comfort, enabling clinicians to better access difficult veins, and reducing overall procedure times.
Advanced fluorescence detection technology, exceptional media performance and instrument reliability—adding vial-activated workflow, advanced ergonomics, blood culture observation and customer-focused data management.
Time to detection is important during the analytical phase. Learn about a full spectrum of blood culture media solutions.
BD Kiestra™ lab automation solutions support clinical microbiology labs with modular, scalable and open architecture solutions that can help increase efficiency, streamline processes and provide consistent results.
The BD Phoenix system has demonstrated performance in detecting both existing and emerging resistance.
Microbiology laboratories play a key role in infectious disease management. At the same time, they face a growing list of challenges, including lab consolidation, increased regulations, decreasing reimbursements and a shortage of skilled staff. That task is complicated by inherent obstacles such as manual processes, the lack of integrated workflows, disparate IT systems and difficulties accessing data.
The BD Phoenix system has demonstrated performance in detecting both existing and emerging resistance.
Now with MedMined Insights (formerly MedMined™ Surveillance Advisor)
The difference is one medication management partner and an integrated platform that unifies complex systems, practices and processes
BD-12850